Company profile
LEI
cee stock exchange group
Issuers / Issuers News
Article print

13 Sep 2013 14:15 
Extraordinary Information
Marketing authorisation for biosimilar infliximab in EU
Attached documents:
Releaser: EGIS Pharmaceuticals PLC
Date Issued: 13 Sep 2013
 
Actual
2014 average
Name
Price
%
Turn. (tEUR)
-
795
0.00
0
^
196
+1.03
13
^
444
+2.54
6
^
228
+0.88
4
^
5,400
+0.99
26
ˇ
717
-0.42
16
^
11,800
+0.85
1,863
^
369
+0.27
1,002
^
4,140
+1.35
9,552
^
314
+0.96
9
^
1,208
+1.34
33
^
3,854
+0.08
6,221
-
161
0.00
1
^
4,320
+0.47
3
Change %: to baseprice
Data delayed by 15 minutes
Indices
Index
Value
Change %
BUX
17,779.76
130.87 (0.74)
1,505.22
5.31 (0.35)
1,153.38
6.94 (0.61)
1,140.58
6.47 (0.57)
1,807.94
-45.15 (-2.44)